STOCK TITAN

[Form 4] Cardinal Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Michelle D. Greene, Chief Information Officer of Cardinal Health, Inc. (CAH), filed a Form 4 reporting a securities transaction dated 08/12/2025. The filing lists transactions in common shares tied to performance share units, shows a reported quantity of 16,362 (marked with an "A") and another listed amount of 34,968 (marked with a "D"); the row shows a price of $0. The explanatory note states these are performance share units that will settle on August 15, 2025.

The form was signed by James E. Barnett, Attorney-in-fact on 08/12/2025. The filing identifies Greene's title and gives a reporting address in Dublin, Ohio. The document does not provide total outstanding shares or percent ownership, so materiality relative to the company-wide share count cannot be determined from this filing alone.

Michelle D. Greene, Chief Information Officer di Cardinal Health, Inc. (CAH), ha depositato un Modulo 4 relativo a una transazione in titoli datata 08/12/2025. La segnalazione elenca operazioni su azioni ordinarie correlate a performance share units, indica una quantità riportata di 16.362 (contrassegnata con 'A') e un altro importo di 34.968 (contrassegnato con 'D'); nella riga è riportato un prezzo di $0. La nota esplicativa precisa che si tratta di performance share units che saranno liquidate il 15 agosto 2025.

Il modulo è stato firmato da James E. Barnett, rappresentante munito di procura in data 08/12/2025. La segnalazione indica il titolo di Greene e un indirizzo di notifica a Dublin, Ohio. Il documento non fornisce il numero totale di azioni in circolazione né la percentuale di proprietà, quindi la rilevanza rispetto al totale delle azioni della società non può essere determinata solo da questa comunicazione.

Michelle D. Greene, Directora de Información de Cardinal Health, Inc. (CAH), presentó un Formulario 4 que reporta una transacción de valores con fecha 08/12/2025. La presentación lista transacciones en acciones ordinarias vinculadas a performance share units, muestra una cantidad reportada de 16,362 (marcada con 'A') y otra cantidad de 34,968 (marcada con 'D'); en la fila figura un precio de $0. La nota explicativa indica que se trata de performance share units que se liquidarán el 15 de agosto de 2025.

El formulario fue firmado por James E. Barnett, apoderado el 08/12/2025. La presentación identifica el cargo de Greene y proporciona una dirección de notificación en Dublin, Ohio. El documento no aporta el total de acciones en circulación ni el porcentaje de participación, por lo que la materialidad respecto al número total de acciones de la compañía no puede determinarse solo con esta presentación.

Michelle D. Greene, Cardinal Health, Inc. (CAH)의 최고정보책임자(CIO),가 2025-08-12자 증권거래를 보고하는 Form 4를 제출했습니다. 해당 보고에는 성과 기반 주식 단위와 연계된 보통주 거래가 기재되어 있으며, 보고된 수량으로 16,362(‘A’ 표시)와 34,968(‘D’ 표시)가 등재되어 있고 해당 행의 가격은 $0로 기재되어 있습니다. 설명란에는 이것이 2025년 8월 15일에 정산될 성과주 단위(performance share units)라고 명시되어 있습니다.

해당 서류는 James E. Barnett, 대리인(Attorney-in-fact)2025-08-12에 서명했습니다. 제출서는 Greene의 직함을 밝히고 오하이오주 더블린의 신고 주소를 기재하고 있습니다. 문서에는 총 발행 주식수나 보유 비율이 제공되어 있지 않아 회사 전체 주식수 대비 중요성은 이 서류만으로는 판단할 수 없습니다.

Michelle D. Greene, Directrice des systèmes d'information de Cardinal Health, Inc. (CAH), a déposé un Formulaire 4 signalant une transaction sur titres datée du 08/12/2025. Le dépôt énumère des opérations sur des actions ordinaires liées à des performance share units, indique une quantité déclarée de 16 362 (marquée 'A') et un autre montant de 34 968 (marqué 'D'); la ligne affiche un prix de 0 $. La note explicative précise qu'il s'agit de performance share units qui seront réglées le 15 août 2025.

Le formulaire a été signé par James E. Barnett, mandataire (Attorney-in-fact) le 08/12/2025. Le dépôt identifie le titre de Greene et fournit une adresse de notification à Dublin, Ohio. Le document ne donne ni le nombre total d'actions en circulation ni le pourcentage de détention, de sorte que la matérialité par rapport au nombre total d'actions de la société ne peut être déterminée à partir de ce seul dossier.

Michelle D. Greene, Chief Information Officer von Cardinal Health, Inc. (CAH), hat ein Formular 4 eingereicht, das eine Wertpapiertransaktion vom 08/12/2025 meldet. Die Einreichung listet Transaktionen in Stammaktien, die an Performance‑Share‑Units gebunden sind, nennt eine gemeldete Stückzahl von 16.362 (mit 'A' gekennzeichnet) und einen weiteren Betrag von 34.968 (mit 'D' gekennzeichnet); in der Zeile ist ein Preis von $0 angegeben. Der erklärende Hinweis besagt, dass es sich um Performance‑Share‑Units handelt, die am 15. August 2025 abgerechnet werden.

Das Formular wurde am 08/12/2025 von James E. Barnett, als Bevollmächtigter (Attorney‑in‑fact), unterzeichnet. Die Einreichung nennt Greenes Funktion und gibt eine Meldeadresse in Dublin, Ohio an. Das Dokument enthält weder die insgesamt ausstehenden Aktien noch den Prozentanteil der Beteiligung, daher lässt sich die Relevanz im Verhältnis zur Gesamtaktienzahl der Gesellschaft nicht allein aus dieser Einreichung bestimmen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider compensation-related securities were reported; grant settles Aug 15, 2025, but materiality to shareholders is unclear without company share base.

The Form 4 shows a transaction dated 08/12/2025 for common shares tied to performance share units, with an acquisition indicator and a $0 price, consistent with a compensation grant or issuance rather than a market purchase. The filing identifies 16,362 in association with an "A" code and references 34,968 with a "D" marker; the explanatory note explicitly states settlement of performance share units on August 15, 2025. Because the filing does not include total outstanding shares or percent ownership, we cannot quantify the ownership change or its effect on dilution or insider stake percentages. This limits assessment of investor impact.

TL;DR: Report appears to reflect routine executive compensation via performance share units; disclosure is standard but lacks context for material assessment.

The reporting person is identified as the Chief Information Officer, and the Form 4 was executed by an attorney-in-fact, which is a standard procedural practice. The presence of a $0 price combined with the explanation that these are performance share units scheduled to settle on August 15, 2025, indicates this is a grant/settlement event rather than an open-market purchase. From a governance perspective, the filing provides the necessary event-level disclosure but omits surrounding context—such as total outstanding shares, prior holdings by the reporting person, or percentage ownership—that investors often need to evaluate significance.

Michelle D. Greene, Chief Information Officer di Cardinal Health, Inc. (CAH), ha depositato un Modulo 4 relativo a una transazione in titoli datata 08/12/2025. La segnalazione elenca operazioni su azioni ordinarie correlate a performance share units, indica una quantità riportata di 16.362 (contrassegnata con 'A') e un altro importo di 34.968 (contrassegnato con 'D'); nella riga è riportato un prezzo di $0. La nota esplicativa precisa che si tratta di performance share units che saranno liquidate il 15 agosto 2025.

Il modulo è stato firmato da James E. Barnett, rappresentante munito di procura in data 08/12/2025. La segnalazione indica il titolo di Greene e un indirizzo di notifica a Dublin, Ohio. Il documento non fornisce il numero totale di azioni in circolazione né la percentuale di proprietà, quindi la rilevanza rispetto al totale delle azioni della società non può essere determinata solo da questa comunicazione.

Michelle D. Greene, Directora de Información de Cardinal Health, Inc. (CAH), presentó un Formulario 4 que reporta una transacción de valores con fecha 08/12/2025. La presentación lista transacciones en acciones ordinarias vinculadas a performance share units, muestra una cantidad reportada de 16,362 (marcada con 'A') y otra cantidad de 34,968 (marcada con 'D'); en la fila figura un precio de $0. La nota explicativa indica que se trata de performance share units que se liquidarán el 15 de agosto de 2025.

El formulario fue firmado por James E. Barnett, apoderado el 08/12/2025. La presentación identifica el cargo de Greene y proporciona una dirección de notificación en Dublin, Ohio. El documento no aporta el total de acciones en circulación ni el porcentaje de participación, por lo que la materialidad respecto al número total de acciones de la compañía no puede determinarse solo con esta presentación.

Michelle D. Greene, Cardinal Health, Inc. (CAH)의 최고정보책임자(CIO),가 2025-08-12자 증권거래를 보고하는 Form 4를 제출했습니다. 해당 보고에는 성과 기반 주식 단위와 연계된 보통주 거래가 기재되어 있으며, 보고된 수량으로 16,362(‘A’ 표시)와 34,968(‘D’ 표시)가 등재되어 있고 해당 행의 가격은 $0로 기재되어 있습니다. 설명란에는 이것이 2025년 8월 15일에 정산될 성과주 단위(performance share units)라고 명시되어 있습니다.

해당 서류는 James E. Barnett, 대리인(Attorney-in-fact)2025-08-12에 서명했습니다. 제출서는 Greene의 직함을 밝히고 오하이오주 더블린의 신고 주소를 기재하고 있습니다. 문서에는 총 발행 주식수나 보유 비율이 제공되어 있지 않아 회사 전체 주식수 대비 중요성은 이 서류만으로는 판단할 수 없습니다.

Michelle D. Greene, Directrice des systèmes d'information de Cardinal Health, Inc. (CAH), a déposé un Formulaire 4 signalant une transaction sur titres datée du 08/12/2025. Le dépôt énumère des opérations sur des actions ordinaires liées à des performance share units, indique une quantité déclarée de 16 362 (marquée 'A') et un autre montant de 34 968 (marqué 'D'); la ligne affiche un prix de 0 $. La note explicative précise qu'il s'agit de performance share units qui seront réglées le 15 août 2025.

Le formulaire a été signé par James E. Barnett, mandataire (Attorney-in-fact) le 08/12/2025. Le dépôt identifie le titre de Greene et fournit une adresse de notification à Dublin, Ohio. Le document ne donne ni le nombre total d'actions en circulation ni le pourcentage de détention, de sorte que la matérialité par rapport au nombre total d'actions de la société ne peut être déterminée à partir de ce seul dossier.

Michelle D. Greene, Chief Information Officer von Cardinal Health, Inc. (CAH), hat ein Formular 4 eingereicht, das eine Wertpapiertransaktion vom 08/12/2025 meldet. Die Einreichung listet Transaktionen in Stammaktien, die an Performance‑Share‑Units gebunden sind, nennt eine gemeldete Stückzahl von 16.362 (mit 'A' gekennzeichnet) und einen weiteren Betrag von 34.968 (mit 'D' gekennzeichnet); in der Zeile ist ein Preis von $0 angegeben. Der erklärende Hinweis besagt, dass es sich um Performance‑Share‑Units handelt, die am 15. August 2025 abgerechnet werden.

Das Formular wurde am 08/12/2025 von James E. Barnett, als Bevollmächtigter (Attorney‑in‑fact), unterzeichnet. Die Einreichung nennt Greenes Funktion und gibt eine Meldeadresse in Dublin, Ohio an. Das Dokument enthält weder die insgesamt ausstehenden Aktien noch den Prozentanteil der Beteiligung, daher lässt sich die Relevanz im Verhältnis zur Gesamtaktienzahl der Gesellschaft nicht allein aus dieser Einreichung bestimmen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greene Michelle D.

(Last) (First) (Middle)
7000 CARDINAL PLACE

(Street)
DUBLIN OH 43017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Information Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/12/2025 A(1) 16,362 A $0 34,968 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects performance share units that will settle on August 15, 2025.
Remarks:
/s/ James E. Barnett, Attorney-in-fact 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Latest News

CAH Latest SEC Filings

CAH Stock Data

35.37B
237.95M
0.29%
89.15%
2.39%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN